ELOCTATE IV 500, from Sanofi, contains Efflaloctocog alpha (genetically recombination), a recombinant human coagulation Factor VIII Fc fusion protein indicated for routine prophylaxis and on-demand treatment of bleeding in hemophilia A. It is supplied as 500 IU 1 bottle with dissolving liquid (YJ code: 6343442D2029).
ELOCTATE IV 500
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →